Selinexor
KCP-330-020
Phase 3 small_molecule completed
Quick answer
Selinexor for Dedifferentiated Liposarcoma is a Phase 3 program (small_molecule) at Karyopharm Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Karyopharm Therapeutics
- Indication
- Dedifferentiated Liposarcoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed